Latest News and Press Releases

        Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement Relates to the submission of a marketing approval application in JapanMarks strong...

Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting Liege, Belgium, 17 October 2023 – 7:00 CEST – Mithra...

Dear Shareholders,  We write to you today with a deep sense of responsibility and transparency, driven by our commitment to the principles of sound corporate governance and the long-term success of...

             Liege, Belgium, 11 October 2023 – 7:00 CEST – Mithra (Euronext Brussels: MITRA) (the "Company"), a company dedicated to Women’s Health, today announces that it has received a...

Mithra to hold joint symposium with partner Gedeon Richter on 11 OctoberFour leading experts will outline why estrogens are critical in contraception and postmenopausal symptomsData show promising...

Mithra Provides an Update in the Context of Recent Market Developments Financial results show Mithra has solid financial foundation and multiple options to financeShareholder meetings called to...

Independent global leaders in medical research on women’s health, Professor Amanda Black and Professor Wulf Utian, to deliver two presentations each on E4E4 is a key active pharmaceutical ingredient...

Mithra Financial Results for First-Half 2023 Good progress on strategy to strengthen balance sheet and refocus on innovative R&DRevenues EUR 7.0 million, driven by Estelle® and Myring®...

Mithra présentera ses résultats financiers du premier semestre 2023 à ses investisseurs lors d'une conférence web le 26 septembre à 14 h 00 CET Liège, Belgique, 22 septembre 2023 – 13 h 30 CET –...

Mithra to Hold Investor Call on H1 2023 Financial Results on September 26 at 14:00 CEST Liege, Belgium, September 21, 2023 – 5:45 pm CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to...